Literature DB >> 2902899

Neuropeptide Y-containing neurons in the rat striatum: ultrastructure and cellular relations with tyrosine hydroxylase- containing terminals and with astrocytes.

C Aoki1, V M Pickel.   

Abstract

The ultrastructural localization of neuropeptide Y (NPY) was comparatively examined in the dorsal (caudate-putamen) and ventral (nucleus accumbens) striatum using the peroxidase-antiperoxidase (PAP) method. In both striatal regions, NPY-like immunoreactivity (IR) was detected in perikarya, dendrites and axons. The labeled perikarya were 15-25 microns in a diameter and contained large, deeply and multiply indented nuclei and prominent Nissl bodies. The labeled dendrites contained a few large (80-150 nm) dense-core vesicles, lacked detectable spines and received few afferents. These morphological characteristics of NPY-IR neurons in both areas are in close accord with previous descriptions for the medium aspiny intrinsic neurons. Axon terminals with terminals with NPY-like IR contain primarily small clear round vesicles, as seen in single or serial sections. These terminals formed junctions that lacked recognizable pre- or post- synaptic densities, but showed parallel spacing between apposed plasmalemmas at presumed synaptic clefts. Targets of the axon terminals with NPY-like IR included unlabeled somata, unlabeled proximal dendrites and labeled and unlabeled distal dendrites. The NPY-IR neurons in the caudate-putamen differed from those in the nucleus accumbens in that (1) there were no recognized appositions between labeled dendrites and labeled terminals, and (2) fewer terminals contained large dense-core vesicles. These findings are consistent with the concept that in the nucleus accumbens, the excitability of the NPY-IR neurons may be more directly modulated by NPY or another transmitter co-existing in the terminals. Catecholamines are known to co-exist with NPY in certain rostrally projecting brainstem nuclei. Therefore, in the two striatal regions, we additionally sought to determine (1) whether the NPY-IR neurons might be modulated by catecholaminergic afferents and (2) whether NPY might co-exist with catecholamines in terminals. Goat antiserum against NPY and rabbit antiserum against tyrosine hydroxylase (TH), the catecholamine-synthesizing enzyme, were simultaneously localized in single sections by PAP and immunoautoradiographic methods, respectively. Quantitative analysis in dually labeled sections from both striatal areas revealed few, if any, direct synaptic contacts between TH-labeled terminals and dendrites containing NPY-like IR. However, there was convergence of separate NPY- and TH-IR terminals on unlabeled dendrites. A few terminals in the nucleus accumbens, but not in the dorsal striatum, showed immunoreactivity methods, to TH and also contained dense-core vesicles with NPY-like IR.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2902899     DOI: 10.1016/0006-8993(88)90637-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Number and type of synapses on the distal dendrite of a rat striatal cholinergic interneuron: a quantitative, ultrastructural study.

Authors:  Rachel J Sizemore; John N J Reynolds; Dorothy E Oorschot
Journal:  J Anat       Date:  2010-07-12       Impact factor: 2.610

Review 2.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

3.  Neuropeptide Y Y5 receptor antagonism attenuates cocaine-induced effects in mice.

Authors:  Gunnar Sørensen; Morten Jensen; Pia Weikop; Ditte Dencker; Søren H Christiansen; Claus Juul Loland; Cecilie Hee Bengtsen; Jørgen Holm Petersen; Anders Fink-Jensen; Gitta Wörtwein; David P D Woldbye
Journal:  Psychopharmacology (Berl)       Date:  2012-02-25       Impact factor: 4.530

4.  Neuropeptide Y signaling modulates the expression of ethanol-induced behavioral sensitization in mice.

Authors:  Dayna M Hayes; Jon R Fee; Thomas J McCown; Darin J Knapp; George R Breese; Inmaculada Cubero; Francisca Carvajal; Jose Manuel Lerma-Cabrera; Montserrat Navarro; Todd E Thiele
Journal:  Addict Biol       Date:  2011-07-18       Impact factor: 4.280

5.  Cocaine-induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortex.

Authors:  C Wahlestedt; F Karoum; G Jaskiw; R J Wyatt; D Larhammar; R Ekman; D J Reis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

6.  Dopaminergic synapses in the caudate of subjects with schizophrenia: relationship to treatment response.

Authors:  Rosalinda C Roberts; Joy K Roche; Robert R Conley; Adrienne C Lahti
Journal:  Synapse       Date:  2009-06       Impact factor: 2.562

7.  Organotypic slice cultures of the rat striatum: an immunocytochemical, histochemical and in situ hybridization study of somatostatin, neuropeptide Y, nicotinamide adenine dinucleotide phosphate-diaphorase, and enkephalin.

Authors:  K Ostergaard; B Finsen; J Zimmer
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

8.  Morphological diversity of GABAergic and cholinergic interneurons in the striatal dorsolateral and ventromedial regions of rats.

Authors:  Yuxin Ma; Qiqi Feng; Lisi Ouyang; Shuhua Mu; Bingbing Liu; Youlan Li; Si Chen; Wanlong Lei
Journal:  Cell Mol Neurobiol       Date:  2013-12-17       Impact factor: 5.046

9.  Ultrastructural analysis of graft-to-host connections, with special reference to dopamine-neuropeptide Y interactions in the rat striatum, after transplantation of fetal mesencephalon cells.

Authors:  J Vuillet; H Moukhles; A Nieoullon; A Daszuta
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

10.  Expression of neuropeptide Y immunoreactivity in the rat nucleus accumbens is under the influence of the dopaminergic mesencephalic pathway.

Authors:  P Salin; L Kerkerian; A Nieoullon
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.